AST of mycobacteria

Meetings and Minutes

 

Meetings and Minutes

 

Invitation to a workshop on MTBC, 4 February, 2020. 

 

Tentative Schedule, EUCAST AMST workshop

Time: 10.00 – 16.00 CET on the 4th of February 2020

Venue: Hotel Scandic Triangeln, Malmö, Sweden (direct train from Copenhagen airport, two stops, leave train at the stop "Triangeln")

10.00-11.00 The EUCAST reference method for the Mycobacterium tuberculosis complex. Frequently asked questions.

11.00-12.00 Calibration of other methods to the EUCAST reference method. The need for further studies and generation of data to set ECOFFs.

12.00-13.00 Sandwich Lunch

13.00-14.30 Short presentations from stakeholders (10 min, agreed beforehand).

14.30-15.30 Discussion led by AMST. Principles for interactions and how to proceed.

15.30-16.00 General discussion.

 

List of participants (8 Jan, 2020):

Emmanuelle Cambau, EUCAST AMST (Chair)

Thomas Schön, EUCAST AMST (Scientific secretary)

Miguel Santin, EUCAST AMST

Miguel Viveiros, EUCAST AMST

Jim Werngren, EUCAST AMST

Daniela Cirillo, EUCAST AMST

Gerard Lina, EUCAST SC/AMST

Christian Giske, EUCAST SC/AMST

Gunnar Kahlmeter, EUCAST SC/EDL

Max Salfinger, University of South Florida Morsani College of Medicine, USA

Diana Machado, Universidade NOVA de Lisboa, Portugal

Lynette Berkeley, FDA, USA

Dorte Bek Folkvardsen, Statens Serum Institut, Denmark

Koné Kaniga, Johnson & Johnson Global Public Health, Division of Janssen Pharmaceutica, USA

Florian Maurer, Research Center Borstel, Germany

Hanne-Leena Hyyryläinen, Finnish Institute for Health and Welfare, Finland

Claudio Köser, University of Cambridge, UK

Vlad Nikolayevskyy, Public Health England, UK

Troels Lillebæk, Statens Serum Institut, Denmark

Nicolas Veziris, Sorbonne Université, France

Alexandra Aubry, Sorbonne Université, France

Emmanuel André, KU Leuven, Belgium

Charles Cooper, BD (Becton, Dickinson and Company), USA

Janine Spafford, BD (Becton, Dickinson and Company), USA

Brigit Quinn, BD (Becton, Dickinson and Company), USA

Kadri Klaos, Tartu University Hospital, Estonia

Erik Svensson, Statens Serum Institut, Denmark

Alexei Korobitsyn, WHO, Switzerland.

Juliano Timm, TB-alliance, USA

Vroni Girbinger, Otsuka, Germany

Norbert Hittel, Otsuka, Germany

Anne Torunn, National Institute of Public Health, Norway